BAZAN RUSSO, Tancredi Didier
 Distribuzione geografica
Continente #
EU - Europa 1.191
AS - Asia 915
NA - Nord America 871
SA - Sud America 163
AF - Africa 37
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.184
Nazione #
US - Stati Uniti d'America 836
RU - Federazione Russa 424
SG - Singapore 372
IT - Italia 292
CN - Cina 192
DE - Germania 148
BR - Brasile 130
FI - Finlandia 112
VN - Vietnam 99
HK - Hong Kong 78
FR - Francia 67
PL - Polonia 60
JP - Giappone 34
IN - India 29
BD - Bangladesh 28
GB - Regno Unito 28
NL - Olanda 20
IQ - Iraq 17
CA - Canada 15
AR - Argentina 13
KR - Corea 12
MX - Messico 12
ZA - Sudafrica 10
AT - Austria 9
ES - Italia 7
KE - Kenya 7
TR - Turchia 7
IE - Irlanda 6
PK - Pakistan 6
SA - Arabia Saudita 6
AU - Australia 5
CI - Costa d'Avorio 5
EG - Egitto 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
EC - Ecuador 4
IR - Iran 4
MA - Marocco 4
MY - Malesia 4
VE - Venezuela 4
LT - Lituania 3
MM - Myanmar 3
NP - Nepal 3
PE - Perù 3
SE - Svezia 3
UY - Uruguay 3
UZ - Uzbekistan 3
BO - Bolivia 2
CO - Colombia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
ID - Indonesia 2
LV - Lettonia 2
PS - Palestinian Territory 2
PT - Portogallo 2
TN - Tunisia 2
UA - Ucraina 2
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
CL - Cile 1
CR - Costa Rica 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
JM - Giamaica 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
NG - Nigeria 1
PA - Panama 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
TO - Tonga 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.184
Città #
Singapore 227
Ashburn 198
San Jose 122
Munich 86
Palermo 86
Moscow 85
Helsinki 84
Hong Kong 68
Rome 58
The Dalles 54
Zgierz 51
Dallas 44
Beijing 38
Hefei 35
Ho Chi Minh City 32
Los Angeles 32
New York 31
Tokyo 31
Hanoi 26
Council Bluffs 25
Lauterbourg 25
Santa Clara 25
Frankfurt am Main 24
Chicago 21
Lappeenranta 15
Buffalo 14
São Paulo 14
Orem 11
Milan 10
Redondo Beach 10
Nuremberg 9
Houston 8
Warsaw 8
Chennai 7
Denver 7
London 7
Mexico City 7
Seoul 7
Volla 7
Atlanta 6
Baghdad 6
Johannesburg 6
Montreal 6
Mumbai 6
Nairobi 6
Paris 6
Salt Lake City 6
Tappahannock 6
Abidjan 5
Bexley 5
Boston 5
Haiphong 5
Ludwigshafen am Rhein 5
Messina 5
New Delhi 5
Rio de Janeiro 5
Roubaix 5
Turin 5
Turku 5
Biên Hòa 4
Bắc Giang 4
Cairo 4
Curitiba 4
Erbil 4
Jyväskylä 4
Melbourne 4
Monza 4
Toronto 4
Vienna 4
Brasília 3
Brooklyn 3
Campinas 3
Casamassima 3
Da Nang 3
Dammam 3
Dhaka 3
Dublin 3
Falkenstein 3
Guarulhos 3
Hải Dương 3
Legnano 3
Lima 3
Manchester 3
Montevideo 3
Naples 3
Philadelphia 3
Phoenix 3
Querétaro 3
Quito 3
Rancho Palos Verdes 3
San Francisco 3
Shanghai 3
Shenzhen 3
Tashkent 3
Albignasego 2
Ankara 2
Barnet 2
Barquisimeto 2
Bergamo 2
Betim 2
Totale 1.885
Nome #
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study 316
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window? 173
Exploring the potential of multiomics liquid biopsy testing in the clinical setting of lung cancer 165
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay 156
Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer 153
Potential agnostic role of BRCA alterations in patients with several solid tumors: One for all, all for one? 153
Roles of Tumor-Educated Platelets (TEPs) in the biology of Non-Small Cell Lung Cancer (NSCLC): A systematic review. “Re-discovering the neglected biosources of the liquid biopsy family” 150
Applications of Platelet Concentrates (PCs) in Regenerative Onco-Urology: A Systematic Review of Literature 139
Clinical utility of ctDNA by amplicon based next generation sequencing in first line non small cell lung cancer patients 138
On-treatment dynamics of circulating extracellular vesicles in the first-line setting of patients with advanced non-small cell lung cancer: the LEXOVE prospective study. 138
BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus Study 135
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer? 130
BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants? 130
Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD) 126
Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints 123
The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors 120
Polθ: emerging synthetic lethal partner in homologous recombination-deficient tumors 118
Scientific Communication and oncology – "The bridge between knowledge and patients" 117
The role of bone modifying agents for secondary osteoporosis prevention and pain control in post-menopausal osteopenic breast cancer patients undergoing adjuvant aromatase inhibitors 100
Potential Applications of PRP-Enhanced Polybutylene Succinate Graft as Vascular Access for Chemotherapy in Oncological Patients: A Systematic Review 96
Recent advances in liquid biopsy for precision oncology: emerging biomarkers and clinical applications in lung cancer 92
POLE-mutated endometrial cancer: new perspectives on the horizon? 74
Homologous recombination repair genetic testing variables and diagnostic paths for prostate cancer patients: a multicenter cohort study 74
Genomics and the early diagnosis of lung cancer 69
Smaller, Cheaper, Faster: Where Next for Liquid Biopsies? 67
Harnessing the potential of genomic characterization of mutational profiles to improve early diagnosis of lung cancer 46
Recent advances in the use of liquid biopsy for the diagnosis and treatment of lung cancer 45
Totale 3.343
Categoria #
all - tutte 9.634
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.634


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202322 0 0 0 0 0 1 7 7 2 1 3 1
2023/2024144 1 5 5 6 22 36 20 6 5 16 2 20
2024/2025883 30 36 66 40 41 76 153 77 55 119 103 87
2025/20262.294 185 91 188 233 249 397 341 224 181 124 81 0
Totale 3.343